Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Cell Genomics
|
June 13, 2024
Shaping human brain development and vulnerability through alternative splicing
Francisco Aya, Juan Valcárcel
Immunotherapy
|
April 28, 2021
Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communication
Francisco Aya, E Azucena González-Navarro, Clara Martínez, et al.
Future Oncology (London, England)
|
September 2, 2016
Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
Francisco Aya, Lydia Gaba, Iván Victoria, et al.
Cancers
|
November 13, 2021
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC
Francisco Aya, Mariana Benegas, Nuria Viñolas, et al.
Immunotherapy
|
April 27, 2016
Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab
Francisco Aya, Aranzazu Fernández-Martínez, Lydia Gaba, et al.
Clinical and Experimental Dermatology
|
January 23, 2026
Pembrolizumab Therapy Leads to Lentigines Resolution and Tumour Control in a Xeroderma Pigmentosum patient with Advanced Cutaneous Squamous Cell Carcinoma
Magí Brufau-Cochs, Sofia Gómez-Martínez, Francisco Aya, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge
Clara Martínez-Vila, Europa Azucena González-Navarro, Cristina Teixido, et al.
Cell Reports
|
April 13, 2024
Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma
Francisco Aya, Pablo Lanuza-Gracia, Abel González-Pérez, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
Clara Martínez-Vila, Cristina Teixido, Francisco Aya, et al.
Journal of Diabetes Investigation
|
May 28, 2021
Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report
Laura Boswell, Gregori Casals, Jesús Blanco, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Cell Genomics
|
June 13, 2024
Shaping human brain development and vulnerability through alternative splicing
Francisco Aya, Juan Valcárcel
Immunotherapy
|
April 28, 2021
Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communication
Francisco Aya, E Azucena González-Navarro, Clara Martínez, et al.
Future Oncology (London, England)
|
September 2, 2016
Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
Francisco Aya, Lydia Gaba, Iván Victoria, et al.
Cancers
|
November 13, 2021
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC
Francisco Aya, Mariana Benegas, Nuria Viñolas, et al.
Immunotherapy
|
April 27, 2016
Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab
Francisco Aya, Aranzazu Fernández-Martínez, Lydia Gaba, et al.
Clinical and Experimental Dermatology
|
January 23, 2026
Pembrolizumab Therapy Leads to Lentigines Resolution and Tumour Control in a Xeroderma Pigmentosum patient with Advanced Cutaneous Squamous Cell Carcinoma
Magí Brufau-Cochs, Sofia Gómez-Martínez, Francisco Aya, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge
Clara Martínez-Vila, Europa Azucena González-Navarro, Cristina Teixido, et al.
Cell Reports
|
April 13, 2024
Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma
Francisco Aya, Pablo Lanuza-Gracia, Abel González-Pérez, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
Clara Martínez-Vila, Cristina Teixido, Francisco Aya, et al.
Journal of Diabetes Investigation
|
May 28, 2021
Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report
Laura Boswell, Gregori Casals, Jesús Blanco, et al.
Page
of 3